StockData
International Stem Cell CORP logo

International Stem Cell CORP (ISCO) stock

ISCOOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 1/30
$0.28+0.00 (+0.89%)

Close on Oct 19, 2026Market cap $2.27MP/E –Yield –

International Stem Cell revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

International Stem Cell's revenue for the twelve months ending Jun 30, 2026 was $9.51M, up 3.4% year over year. For fiscal 2025 it was $9.10M, up 0.2% from the year before. Over ten years it grew 1.9% a year on average. The highest annual figure on record is $11.09M in fiscal 2018.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$9.10M+0.2%
FY2024Dec 31, 2024$9.09M+16.6%
FY2023Dec 31, 2023$7.79M-4.8%
FY2022Dec 31, 2022$8.18M+14.0%
FY2021Dec 31, 2021$7.18M+0.7%
FY2020Dec 31, 2020$7.13M-24.7%
FY2019Dec 31, 2019$9.47M-14.6%
FY2018Dec 31, 2018$11.09M+48.7%
FY2017Dec 31, 2017$7.46M+4.1%
FY2016Dec 31, 2016$7.17M-5.1%
FY2015Dec 31, 2015$7.55M+7.6%
FY2014Dec 31, 2014$7.02M+14.2%
FY2013Dec 31, 2013$6.15M+34.6%
FY2012Dec 31, 2012$4.57M+0.8%
FY2011Dec 31, 2011$4.53M+189.0%
FY2010Dec 31, 2010$1.57M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.68M+9.3%
Q1 FY2026Mar 31, 2026$2.32M+8.7%
Q4 FY2025Dec 31, 2025$2.16M-11.9%
Q3 FY2025Sep 30, 2025$2.37M+8.7%
Q2 FY2025Jun 30, 2025$2.45M+5.0%
Q1 FY2025Mar 31, 2025$2.13M0.0%
Q4 FY2024Dec 31, 2024$2.45M+29.5%
Q3 FY2024Sep 30, 2024$2.18M+10.4%
Q2 FY2024Jun 30, 2024$2.33M+26.6%
Q1 FY2024Mar 31, 2024$2.13M+2.1%
Q4 FY2023Dec 31, 2023$1.89M-22.3%
Q3 FY2023Sep 30, 2023$1.97M+15.9%
Q2 FY2023Jun 30, 2023$1.84M-9.2%
Q1 FY2023Mar 31, 2023$2.09M+3.3%
Q4 FY2022Dec 31, 2022$2.43M+32.6%
Q3 FY2022Sep 30, 2022$1.70M+2.7%
Q2 FY2022Jun 30, 2022$2.03M+37.3%
Q1 FY2022Mar 31, 2022$2.02M+36.4%
Q2 FY2021Jun 30, 2021$1.83M+1.2%
Q1 FY2021Mar 31, 2021$1.66M-29.7%
Q4 FY2020Dec 31, 2020$1.48M-48.0%
Q3 FY2020Sep 30, 2020$1.48M-29.3%
Q2 FY2020Jun 30, 2020$1.81M-21.9%
Q1 FY2020Mar 31, 2020$2.36M+6.4%
Q4 FY2019Dec 31, 2019$2.84M+27.6%
Q3 FY2019Sep 30, 2019$2.10M-34.4%
Q2 FY2019Jun 30, 2019$2.32M-23.6%
Q1 FY2019Mar 31, 2019$2.22M-15.8%
Q4 FY2018Dec 31, 2018$2.22M+20.7%
Q3 FY2018Sep 30, 2018$3.20M+73.0%
Q2 FY2018Jun 30, 2018$3.04M+72.4%
Q1 FY2018Mar 31, 2018$2.63M+31.3%
Q4 FY2017Dec 31, 2017$1.84M+9.0%
Q3 FY2017Sep 30, 2017$1.85M-4.9%
Q2 FY2017Jun 30, 2017$1.76M-8.0%
Q1 FY2017Mar 31, 2017$2.01M–
Q4 FY2016Dec 31, 2016$1.69M–
Q3 FY2016Sep 30, 2016$1.94M–
Q2 FY2016Jun 30, 2016$1.92M–

More International Stem Cell figures

See a number that looks wrong?